Inventor · disambiguated record
Christopher Hartley
Also filed as: HARTLEY CHRISTOPHER · HARTLEY CHRISTOPHER E · HARTLEY CHRISTOPHER EDWARD
3 granted patents·9 pending applications·9 citations·filing 2000–2010
57Inventor score
Files withHENDERSON MORLEY PLC4HENDERSON MORLEY RES & DEV LTD3HENDERSON MORELY RES AND DEV L1SAMUEL PETER1
Top patents by PatentIndex Score
12 records- 0164US6894030B2Treatment of DNA viral infectionsHENDERSON MORLEY RES & DEV LTD·Filed 2000·Granted May 17, 2005·9 cites·7 claims
- 0249US7534768B2Treatment of DNA viral infectionsHENDERSON MORELY RES AND DEV L·Filed 2004·Granted May 19, 2009·0 cites·2 claims
- 0340US2006122174A1Antiviral treatmentHENDERSON MORLEY RES & DEV LTD·Filed 2006·Application pending·0 cites
- 0438US2007219142A1Composition Comprising a Diuretic and/or Cardiac Glycosed for the Treatment of Dna Viral Infections of the EyeHENDERSON MORLEY PLC·Filed 2005·Application pending·0 cites
- 0538US2006029684A1Synergistic treatment of DNA viral infectionsHENDERSON MORLEY RES & DEV LTD·Filed 2005·Application pending·0 cites
- 0636US2008220066A1Anti-Viral Topical Gel Formulations Containing a Diuretic Such as Furosemide and/or a Cardiac Glycoside Such as DigoxinHENDERSON MORLEY PLC·Filed 2006·Application pending·0 cites
- 0736US2009074845A1Transdermal active principle delivery meansHENDERSON MORLEY PLC·Filed 2006·Application pending·0 cites
- 0835US8075521B2CatheterSAMUEL PETER·Filed 2007·Granted Dec 13, 2011·0 cites·9 claims
- 0933US2003049331A1Synergistic treatment of dna viral infectionsFiled 2000·Application pending·0 cites
- 1031US2010137232A1Composition comprising a diuretic and a cardiac glycoside for the treatment of dna viral infections of the eyeHENDERSON MORLEY PLC·Filed 2010·Application pending·0 cites
- 1129US2004034016A1Diuretic or sulphonylurea for use in antiviral treatmentFiled 2001·Application pending·0 cites
- 1228US2003181394A1Pharmaceutical compositionFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Hartley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →